Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

91.94 

-0.04 0.0%

as of Oct 16 '19

52 Week Range:

60.10 98.52


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. It offers the Medidata Clinical Cloud, a platform, pioneering analytics, and clinical technology for the development and commercialization of new therapies. The company's platform solutions include data capture and management, and trial planning and management. It also provides professional services, such as implementation, sponsor enablement, strategic consulting, partner support, and e-learning and training. The company markets and sells its cloud-based solutions through a direct sales force and through relationships with channel and strategic partners. It serves pharmaceutical, biotechnology, medical device, and diagnostics companies; academic research centers, government, and other non-profit organizations; and other non-profit organizations; and contract research organizations and other entities engaged in clinical trials. The company has a strategic collaboration with Mapi Research Trust. Medidata Solutions, Inc. was founded in 1999 and is headquartered in New York, New York.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Equity (BVPS) -8.98
0.44
1.06
1.58
2.73
4.02
4.58
5.37
6.57
7.98
9.68
growth rate 100.0% 140.9% 49.1% 72.8% 47.3% 13.9% 17.3% 22.4% 21.5% 21.3%
Earnings BIT -17.35
7.04
23.72
22.97
28.07
18.38
25.85
29.23
48.69
60.71
50.99
growth rate 100.0% 236.9% -3.2% 22.2% -34.5% 40.6% 13.1% 66.6% 24.7% -16.0%
Avg.PE 62.50
25.19
13.61
55.25
196.08
410.64
159.39
110.43
90.47
84.78
growth rate -59.7% -46.0% 306.0% 254.9% 109.4% -61.2% -30.7% -18.1% -6.3%
ROA -31.37
4.74
15.14
22.66
8.70
4.18
1.02
2.01
3.85
4.76
5.30
growth rate 100.0% 219.4% 49.7% -61.6% -52.0% -75.6% 97.1% 91.5% 23.6% 11.3%
ROE 28.90
25.60
63.95
50.76
14.64
9.06
2.48
4.80
8.45
9.87
9.20
growth rate -11.4% 149.8% -20.6% -71.2% -38.1% -72.6% 93.6% 76.0% 16.8% -6.8%
ROIC 59.96
50.28
14.54
7.21
3.90
4.67
6.49
6.03
9.26
growth rate -16.1% -71.1% -50.4% -45.9% 19.7% 39.0% -7.1% 53.6%
Cur. Ratio 0.49
1.08
1.61
2.08
2.46
3.04
3.77
3.16
3.92
1.49
2.71
growth rate 120.4% 49.1% 29.2% 18.3% 23.6% 24.0% -16.2% 24.1% -62.0% 81.9%
Quick Ratio 0.39
1.01
1.46
1.84
2.22
2.86
3.60
2.98
3.70
1.39
2.41
growth rate 159.0% 44.6% 26.0% 20.7% 28.8% 25.9% -17.2% 24.2% -62.4% 73.4%
Leverage 7.09
3.09
1.82
1.58
2.54
2.35
2.42
2.03
2.10
1.45
growth rate -56.4% -41.1% -13.2% 60.8% -7.5% 3.0% -16.1% 3.5% -31.0%
Balance Sheet Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Acct.Receivable 25.20
18.90
34.30
33.87
49.82
46.20
68.48
90.59
115.22
110.69
170.74
growth rate -25.0% 81.5% -1.3% 47.1% -7.3% 48.2% 32.3% 27.2% -3.9% 54.3%
Acct.Payable 19.60
23.87
47.56
3.74
6.28
6.20
5.01
7.48
growth rate 21.8% 99.3% -92.1% 68.1% -1.3% -19.2% 49.4%
Cur.Assets 44.60
101.70
132.90
147.67
182.70
304.55
357.85
383.20
518.78
641.02
462.49
growth rate 128.0% 30.7% 11.1% 23.7% 66.7% 17.5% 7.1% 35.4% 23.6% -27.9%
Total Assets 75.20
143.40
157.90
189.84
224.63
573.35
622.22
684.18
817.89
1,061.23
913.21
growth rate 90.7% 10.1% 20.2% 18.3% 155.2% 8.5% 10.0% 19.5% 29.8% -14.0%
Cash 9.80
39.40
16.00
45.21
32.68
22.33
39.52
49.56
93.52
237.33
105.44
growth rate 302.0% -59.4% 182.6% -27.7% -31.7% 77.0% 25.4% 88.7% 153.8% -55.6%
Inventory 0.00 0.00 0.00 0.00 0.00
growth rate
Cur.Liabilities 90.40
94.00
82.30
70.94
74.22
100.19
94.84
121.08
132.33
429.06
170.70
growth rate 4.0% -12.5% -13.8% 4.6% 35.0% -5.3% 27.7% 9.3% 224.2% -60.2%
Liabilities 151.60
123.20
106.80
85.72
82.54
347.54
357.52
400.02
415.90
548.62
281.76
growth rate -18.7% -13.3% -19.7% -3.7% 321.1% 2.9% 11.9% 4.0% 31.9% -48.6%
LT Debt 15.50
0.80
0.10
0.14
0.00
229.71
240.89
249.49
263.40
92.84
88.37
growth rate -94.8% -87.5% 36.0% -100.0% 4.9% 3.6% 5.6% -64.8% -4.8%
Equity -63.16
20.20
51.10
104.12
142.09
225.81
264.70
284.16
401.99
512.61
631.45
growth rate 100.0% 153.0% 103.8% 36.5% 58.9% 17.2% 7.4% 41.5% 27.5% 23.2%
Common Shares 14.00
41.00
48.00
49.00
51.00
54.00
55.00
57.00
57.00
60.00
61.00
growth rate 192.9% 17.1% 2.1% 4.1% 5.9% 1.9% 3.6% 0.0% 5.3% 1.7%
Cash Flow Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Capital Expenditures 5.20
4.80
7.40
4.41
5.74
30.51
15.82
19.02
25.66
44.62
40.08
growth rate -7.7% 54.2% -40.4% 30.2% 431.3% -48.2% 20.3% 34.9% 73.9% -10.2%
Cash Dividends 0.00
2.30
0.00
0.00
0.00
0.00
growth rate -100.0%
Cash From OA 9.50
28.20
6.20
28.67
13.25
69.60
67.45
88.59
88.77
121.75
89.18
growth rate 196.8% -78.0% 362.4% -53.8% 425.5% -3.1% 31.4% 0.2% 37.2% -26.8%
FCF per Share 0.56
-0.03
0.41
0.15
0.48
0.63
1.16
0.93
1.55
0.73
growth rate -100.0% 100.0% -63.4% 220.0% 31.3% 84.1% -19.8% 66.7% -52.9%
Sale Purchase of Stock 1.76
5.89
-0.38
9.74
12.70
12.36
19.59
growth rate 234.0% -100.0% 100.0% 30.3% -2.7% 58.5%
FCF 4.00
23.00
-1.00
24.00
8.00
39.00
46.00
68.00
63.00
77.00
49.00
growth rate 475.0% -100.0% 100.0% -66.7% 387.5% 18.0% 47.8% -7.4% 22.2% -36.4%
Income Statement Dec '08 Dec '09 Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18
Sales 105.70
140.40
166.40
184.46
218.35
276.85
335.07
392.51
458.49
544.21
635.70
growth rate 32.8% 18.5% 10.9% 18.4% 26.8% 21.0% 17.1% 16.8% 18.7% 16.8%
Op.Income -15.70
8.80
23.30
39.40
18.02
16.66
25.85
29.23
48.69
60.71
50.99
growth rate 100.0% 164.8% 69.1% -54.3% -7.5% 55.1% 13.1% 66.6% 24.7% -16.0%
IBT -17.40
7.00
23.70
22.97
28.07
18.38
6.51
15.78
35.79
53.04
50.14
growth rate 100.0% 238.6% -3.1% 22.2% -34.5% -64.6% 142.2% 126.9% 48.2% -5.5%
Net Income -18.30
5.20
22.80
39.40
18.02
16.66
6.09
13.17
28.01
47.58
51.92
growth rate 100.0% 338.5% 72.8% -54.3% -7.5% -63.4% 116.1% 112.7% 69.9% 9.1%
EPS -1.38
0.13
0.47
0.80
0.35
0.31
0.11
0.23
0.49
0.80
0.85
growth rate 100.0% 261.5% 70.2% -56.3% -11.4% -64.5% 109.1% 113.0% 63.3% 6.3%
Gross Profit 55.30
90.40
114.20
131.63
155.69
206.94
250.15
302.72
345.88
417.41
476.54
growth rate 63.5% 26.3% 15.3% 18.3% 32.9% 20.9% 21.0% 14.3% 20.7% 14.2%
R&D 19.30
22.50
25.80
29.57
42.28
51.20
71.76
92.32
112.60
138.56
162.79
growth rate 16.6% 14.7% 14.6% 43.0% 21.1% 40.1% 28.7% 22.0% 23.1% 17.5%

Quarterly Statements

Item Name Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Earnings BIT 12.84
14.12
10.97
5.14
7.01
growth rate 10.0% -22.3% -53.1% 36.2%
Balance Sheet Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Acct.Receivable 137.17
163.18
170.74
177.85
198.17
growth rate 19.0% 4.6% 4.2% 11.4%
Acct.Payable 6.53
6.66
7.48
8.14
10.67
growth rate 2.1% 12.3% 8.8% 31.2%
Cur.Assets 599.79
408.08
462.49
443.97
466.23
growth rate -32.0% 13.3% -4.0% 5.0%
Total Assets 1,102.79
867.79
913.21
996.70
1,023.77
growth rate -21.3% 5.2% 9.1% 2.7%
Cash 120.30
83.50
105.44
109.05
139.10
growth rate -30.6% 26.3% 3.4% 27.6%
Inventory
growth rate
Cur.Liabilities 425.04
161.96
170.70
172.62
181.77
growth rate -61.9% 5.4% 1.1% 5.3%
Liabilities 541.43
273.80
281.76
359.98
363.31
growth rate -49.4% 2.9% 27.8% 0.9%
LT Debt 91.91
89.51
88.37
86.61
84.84
growth rate -2.6% -1.3% -2.0% -2.0%
Equity 561.36
593.99
631.45
636.73
660.46
growth rate 5.8% 6.3% 0.8% 3.7%
Common Shares 0.64
0.66
0.66
0.67
0.68
growth rate 2.5% 0.3% 2.0% 0.7%
Cash Flow Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Capital Expenditures 8.37
9.41
11.15
18.19
14.18
growth rate 12.4% 18.6% 63.1% -22.1%
Cash Dividends
growth rate
Cash From OA 18.80
33.47
31.93
6.08
24.32
growth rate 78.0% -4.6% -81.0% 299.8%
Sale Purchase of Stock 7.21
growth rate
FCF 10.43
24.06
20.78
-12.10
10.15
growth rate 130.8% -13.7% -100.0% 100.0%
Income Statement Jun '18 Sep '18 Dec '18 Mar '19 Jun '19
Sales 155.91
163.41
167.19
173.50
180.46
growth rate 4.8% 2.3% 3.8% 4.0%
Op.Income 12.84
14.12
10.97
5.14
7.01
growth rate 10.0% -22.3% -53.1% 36.2%
IBT 17.19
12.71
10.49
4.79
1.78
growth rate -26.1% -17.5% -54.4% -62.9%
Net Income 16.59
10.69
14.32
11.15
7.89
growth rate -35.6% 34.0% -22.2% -29.2%
EPS
growth rate
Gross Profit 118.40
121.18
124.06
127.50
130.86
growth rate 2.3% 2.4% 2.8% 2.6%
R&D 40.79
40.63
43.85
46.49
48.48
growth rate -0.4% 7.9% 6.0% 4.3%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (69.46)

YOY Growth Grade:

C (60.33)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 127.25 127.69 43.42
EPS / Growth 17.5% 0.72 21.2%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 36.7%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 17.5% 25.2% 25.2%
Future PE 35.02 46.86 46.86
Future EPS 3.61 6.79 6.79
Value Price
MOS %
31.29
-66.0%
78.61
-14.5%
78.61
-14.5%
MOS Price 15.65 39.30 39.30
IRT 18.56 14.61 14.61

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.